Clínic-IDIBAPS optimizes its academic CAR-T therapy against multiple myeloma to address relapse
Researchers from Clínic-IDIBAPS, as part of the Clínic Barcelona Comprehensive Cancer Centre — a centre driven by Clínic, IDIBAPS and the Universit...
News from Institute of Cancer and Blood Diseases
Hospital Clínic marks 25 years of home-based haematology care
The Home Care Unit (UAD) of the Clínic Barcelona Comprehensive Cancer Centre marked its 25th anniversary on 5 March 2026 with a commemorative event...
February: Cholangiocarcinoma Awareness Month
February, particularly February 19, is dedicated to raising awareness about cholangiocarcinoma, a rare tumour in our setting where most patients ar...
Viro-immunotherapy combination shows promising results in breast cancer patients with poor initial chemotherapy response
A study led by Clínic Barcelona Comprehensive Cancer Centre (4CB)- – driven by Clínic Barcelona, IDIBAPS and UB-, and sponsored by SOLTI, shows tha...
CAR-T ARI-0001 shows high response rates in adult patients with acute lymphoblastic leukemia
Developed by Clínic-IDIBAPS teams as part of the Clínic Barcelona Comprehensive Cancer Centre, this treatment confirms its therapeutic potential in...
Clínic Barcelona Comprehensive Cancer Centre highlights 2025 achievements on World Cancer Day
On World Cancer Day, held every year on 4 February, Clínic Barcelona Comprehensive Cancer Centre (4CB) highlights its excellence in patient care an...
Clínic Barcelona ranks as the third best public hospital in Spain according to the Merco Salud 2025 ranking
The hospital, which has also been recognized as the best public hospital in Catalonia, stands out with five services ranked first: Digestive System...
FERO Foundation joins Clínic Barcelona Comprehensive Cancer Centre Governing Council
Hospital Clínic Barcelona and the FERO Foundation have signed an agreement whereby the foundation joins the Clínic Barcelona Comprehensive Cancer C...
A new study shows targeted immunotherapy halves metastasis risk in high-risk early HER2+ breast cancer
The international DESTINY-Breast05 trial, published in The New England Journal of Medicine, demonstrates that the antibody-drug conjugate trastuzum...
Innovations in transplants and advanced therapies: key contributions from the Clínic Barcelona Comprehensive Cancer Centre at ASH 2025
Hospital Clínic Barcelona and IDIBAPS, through the Clínic Barcelona Comprehensive Cancer Centre (4CB), had a prominent presence at the ASH 2025 Ann...